BIVIX vs. WALSX
BIVIX (Invenomic Fund Institutional Class) and WALSX (Wasatch Long/Short Alpha Fund) are both Long-Short funds. Over the past 3 years, BIVIX returned 2.90%/yr vs 7.15%/yr for WALSX. Their 0.04 correlation means their historical movements had little consistent relationship. BIVIX charges 3.17%/yr vs 1.75%/yr for WALSX.
Performance
BIVIX vs. WALSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVIX achieves a 6.78% return, which is significantly lower than WALSX's 13.20% return.
BIVIX
- 1D
- -1.10%
- 1M
- 14.34%
- 6M
- 9.88%
- YTD
- 6.78%
- 1Y
- 15.80%
- 3Y*
- 2.90%
- 5Y*
- 15.96%
- 10Y*
- —
- ALL TIME*
- 16.79%
WALSX
- 1D
- -0.36%
- 1M
- 0.58%
- 6M
- 8.01%
- YTD
- 13.20%
- 1Y
- 7.26%
- 3Y*
- 7.15%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 7.06%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $0.00 | $0.00 | $0.00 | |
| $0.00 | $0.00 | $0.00 |
BIVIX vs. WALSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIVIX Invenomic Fund Institutional Class | 6.78% | 4.63% | -8.81% | 16.80% | 50.01% | 15.33% |
WALSX Wasatch Long/Short Alpha Fund | 13.20% | -12.79% | 7.24% | 27.75% | -8.38% | 12.20% |
Correlation
The correlation between BIVIX and WALSX is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.04 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2021 | 0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVIX vs. WALSX — Risk / Return Rank
BIVIX
WALSX
BIVIX vs. WALSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund Institutional Class (BIVIX) and Wasatch Long/Short Alpha Fund (WALSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIVIX | WALSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.09 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.58 | 0.69 | -0.11 |
| Martin ratioReturn relative to average drawdown | 1.58 | 1.40 | +0.18 |
Loading charts...
Drawdowns
BIVIX vs. WALSX - Drawdown Comparison
The maximum BIVIX drawdown since its inception was -26.95%, which is greater than WALSX's maximum drawdown of -25.28%. Use the drawdown chart below to compare losses from any high point for BIVIX and WALSX.
Loading charts...
Drawdown Indicators
| BIVIX | WALSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.95% | -25.28% | -1.67% |
Max Drawdown (1Y)Largest decline over 1 year | -26.95% | -10.76% | -16.19% |
Max Drawdown (3Y)Largest decline over 3 years | -26.95% | -25.28% | -1.67% |
Max Drawdown (5Y)Largest decline over 5 years | -26.95% | — | — |
Current DrawdownCurrent decline from peak | -6.71% | -13.08% | +6.37% |
Average DrawdownAverage peak-to-trough decline | -6.03% | -9.71% | +3.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.90% | 5.31% | +4.59% |
Volatility
BIVIX vs. WALSX - Volatility Comparison
Invenomic Fund Institutional Class (BIVIX) has a higher volatility of 17.23% compared to Wasatch Long/Short Alpha Fund (WALSX) at 4.98%. This indicates that BIVIX's price experiences larger fluctuations and is considered to be riskier than WALSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVIX | WALSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.23% | 4.98% | +12.25% |
Volatility (6M)Calculated over the trailing 6-month period | 29.33% | 12.35% | +16.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.70% | 16.26% | +16.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.36% | 16.38% | +2.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.61% | 16.38% | +2.23% |
BIVIX vs. WALSX - Expense Ratio Comparison
BIVIX has a 3.17% expense ratio, which is higher than WALSX's 1.75% expense ratio.
Dividends
BIVIX vs. WALSX - Dividend Comparison
BIVIX's dividend yield for the trailing twelve months is around 2.06%, while WALSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIVIX Invenomic Fund Institutional Class | 2.06% | 2.20% | 3.95% | 20.15% | 27.91% | 16.08% | 3.15% | 3.19% | 4.79% | 1.21% |
WALSX Wasatch Long/Short Alpha Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIVIX and WALSX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVIX has higher volatility (17.23%) compared to WALSX (4.98%). In terms of maximum drawdown, BIVIX dropped -26.95% vs WALSX's -25.28%.
BIVIX currently has the higher Sharpe Ratio (0.48 vs 0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVIX and WALSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer